HOOK - HOOKIPA Pharma Inc.
NASDAQ
->
Healthcare
->
Biotechnology
New York,
United States
Type: Equity
HOOK price evolution
HOOK
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $117.1 | $107.68 | $135.59 | $109.6 |
| Short term investments | ||||
| Net receivables | $19.27 | $23.05 | $20.46 | $18.46 |
| Inventory | ||||
| Total current assets | $147.12 | $139.47 | $168.14 | $139.91 |
| Long term investments | $0.42 | $0.42 | $0.42 | $0.42 |
| Property, plant & equipment | $13.21 | $23.03 | $21.54 | $21.66 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.22 | $24.54 | $22.97 | $23.18 |
| Total investments | $0.42 | $0.42 | $0.42 | $0.42 |
| Total assets | $161.34 | $164.01 | $191.11 | $163.09 |
| Current liabilities | ||||
| Accounts payable | $12.5 | $8.93 | $11.64 | $7.08 |
| Deferred revenue | $34.3 | $39.77 | $47.16 | $49.33 |
| Short long term debt | $2.76 | $2.52 | $2.63 | $3.79 |
| Total current liabilities | $41.99 | $40.58 | $46.24 | $44.21 |
| Long term debt | $3.8 | $1.33 | $1.65 | $1.97 |
| Total noncurrent liabilities | $29.49 | $28.38 | $32.53 | $35.4 |
| Total debt | $6.56 | $3.85 | $4.28 | $5.76 |
| Total liabilities | $71.48 | $68.96 | $78.78 | $79.61 |
| Shareholders' equity | ||||
| Retained earnings | -$369.26 | -$344.44 | -$325.38 | -$307.36 |
| Other shareholder equity | -$7.93 | -$6.03 | -$7.24 | -$7.17 |
| Total shareholder equity | $89.86 | $95.05 | $112.33 | $83.48 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $117.1 | $113.03 | $66.49 | $142.74 |
| Short term investments | ||||
| Net receivables | $19.27 | $22.01 | $21.17 | $20.66 |
| Inventory | ||||
| Total current assets | $147.12 | $147.2 | $102.14 | $171.5 |
| Long term investments | $0.42 | $0.42 | $0.42 | $0.43 |
| Property, plant & equipment | $13.21 | $21.98 | $22.11 | $13.97 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.22 | $23.26 | $23.91 | $16.31 |
| Total investments | $0.42 | $0.42 | $0.42 | $0.43 |
| Total assets | $161.34 | $170.45 | $126.05 | $187.82 |
| Current liabilities | ||||
| Accounts payable | $12.5 | $5.49 | $8.76 | $8.01 |
| Deferred revenue | $34.3 | $41.35 | $5.56 | $4.53 |
| Short long term debt | $2.76 | $3.28 | $4.47 | $2 |
| Total current liabilities | $41.99 | $35.63 | $27.65 | $21.14 |
| Long term debt | $3.8 | $0.91 | $6.13 | $8.36 |
| Total noncurrent liabilities | $29.49 | $32.3 | $8.8 | $10.55 |
| Total debt | $6.56 | $6.5 | $10.6 | $10.35 |
| Total liabilities | $71.48 | $67.94 | $36.45 | $31.69 |
| Shareholders' equity | ||||
| Retained earnings | -$369.26 | -$287.68 | -$222.77 | -$147.1 |
| Other shareholder equity | -$7.93 | -$7.16 | -$4.78 | -$6.07 |
| Total shareholder equity | $89.86 | $102.52 | $89.59 | $156.12 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7.41 | $6.87 | $2.68 | $3.18 |
| Cost of revenue | ||||
| Gross Profit | $7.41 | $6.87 | $2.68 | $3.18 |
| Operating activities | ||||
| Research & development | $21.16 | $24.63 | $19.71 | $20.93 |
| Selling, general & administrative | $4.37 | $4.91 | $4.45 | $4.9 |
| Total operating expenses | $38.3 | $29.54 | $24.15 | $25.83 |
| Operating income | -$30.89 | -$22.67 | -$21.47 | -$22.66 |
| Income from continuing operations | ||||
| EBIT | -$24.61 | -$19.02 | -$17.92 | -$19.35 |
| Income tax expense | $0.16 | $0.2 | ||
| Interest expense | $0.05 | $0.05 | $0.1 | $0.12 |
| Net income | ||||
| Net income | -$24.82 | -$19.07 | -$18.02 | -$19.68 |
| Income (for common shares) | -$24.82 | -$19.07 | -$18.02 | -$19.68 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20.13 | $14.25 | $18.45 | $19.58 |
| Cost of revenue | ||||
| Gross Profit | $20.13 | $14.25 | $18.45 | $19.58 |
| Operating activities | ||||
| Research & development | $86.42 | $68.64 | $82.85 | $54.79 |
| Selling, general & administrative | $18.63 | $18.76 | $17.27 | $18.08 |
| Total operating expenses | $117.82 | $87.4 | $100.12 | $72.87 |
| Operating income | -$97.69 | -$73.16 | -$81.67 | -$53.28 |
| Income from continuing operations | ||||
| EBIT | -$80.89 | -$64 | -$74.77 | -$43.3 |
| Income tax expense | $0.37 | $0.23 | $0 | |
| Interest expense | $0.32 | $0.69 | $0.9 | $0.79 |
| Net income | ||||
| Net income | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| Income (for common shares) | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$24.82 | -$19.07 | -$18.02 | -$19.68 |
| Operating activities | ||||
| Depreciation | $1.28 | $0.49 | $0.87 | $0.92 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.42 | $0.57 | $0.7 | $0.66 |
| Total cash flows from operations | -$11.22 | -$24.12 | -$19.33 | -$2.85 |
| Investing activities | ||||
| Capital expenditures | -$0.42 | -$3.02 | -$0.45 | -$0.27 |
| Investments | ||||
| Total cash flows from investing | -$0.42 | -$3.02 | -$0.45 | -$0.27 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $21.25 | -$0.4 | $28.19 | $0 |
| Net borrowings | -$1.16 | -$0.6 | ||
| Total cash flows from financing | $21.25 | -$0.66 | $45.81 | -$0.73 |
| Effect of exchange rate | -$0.18 | -$0.12 | -$0.05 | $0.43 |
| Change in cash and equivalents | $9.6 | -$27.8 | $26.04 | -$3.86 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$81.58 | -$64.92 | -$75.67 | -$44.08 |
| Operating activities | ||||
| Depreciation | $3.55 | $3.6 | $4.64 | $4.15 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.35 | $5.04 | $7.64 | $8.66 |
| Total cash flows from operations | -$57.52 | -$20 | -$66.02 | -$39.34 |
| Investing activities | ||||
| Capital expenditures | -$4.16 | -$5.02 | -$12.58 | -$2.37 |
| Investments | ||||
| Total cash flows from investing | -$4.16 | -$5.02 | -$12.58 | -$2.37 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $49.04 | $45.69 | $0.2 | $42.64 |
| Net borrowings | -$1.75 | -$2.85 | -$0.44 | -$1.42 |
| Total cash flows from financing | $65.67 | $72.27 | -$0.23 | $73.42 |
| Effect of exchange rate | $0.09 | -$0.72 | $2.57 | -$2.11 |
| Change in cash and equivalents | $3.99 | $47.26 | -$78.83 | $31.71 |
News
Fundamentals
| Market cap | $75.70M |
|---|---|
| Enterprise value | -$34.84M |
| Shares outstanding | 98.95M |
| Revenue | $20.13M |
|---|---|
| EBITDA | -$77.34M |
| EBIT | -$80.89M |
| Net Income | -$81.58M |
| Revenue Q/Q | -5.38% |
| Revenue Y/Y | 41.27% |
| P/E ratio | -0.93 |
|---|---|
| EV/Sales | -1.73 |
| EV/EBITDA | 0.45 |
| EV/EBIT | 0.43 |
| P/S ratio | 3.76 |
| P/B ratio | 0.77 |
| Book/Share | 0.99 |
| Cash/Share | 1.18 |
| EPS | -$0.82 |
|---|---|
| ROA | -48.02% |
| ROE | -85.71% |
| Debt/Equity | 0.80 |
|---|---|
| Net debt/EBITDA | 0.59 |
| Current ratio | 3.50 |
| Quick ratio | 3.50 |